hamburger-icon
close-icon

invest-iconInvest

trade-iconTrade

depository-iconInsurance

watch-iconPMS

depository-iconTrading Platforms

depository-iconDepository

watch-iconWatch Markets

depository-iconFPI

watch-iconMerchant Banking

watch-iconInstitutional Broking

watch-iconMTF

partner-iconBecome a Partner

partner-iconKnowledge Center

watch-iconResearch

about-iconAbout Us

support-iconSupport

support-iconPricing

support-iconQuick Links

support-iconBlog

hamburger-icon
close-icon

Nestle India Ltd

  • BSE Code : 500790
  • NSE Symbol : NESTLEIND
  • ISIN : INE239A01024
  • Industry :FOOD - PROCESSING - MNC
Trade Now

up-arrow 2,504.40 58.90(2.41%)

Open Price (₹)

2,464.00

Prev. Close (₹)

2,445.50

Volume (No’s)

252,529

Market Cap (₹)

241,463.52

Low Price (₹)

2,459.80

High Price (₹)

2,518.75

 

Board Meetings

Start Date End Date Purpose
26-Mar-2024 25-Apr-2024 NESTLE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2024 inter alia to consider and approve Further to our letter dated PKR:SG: 88:23 dated 19th December 2023 the audited financial results of the Company for the three months period from 1st January 2024 to 31st March 2024 (fifth quarter) and extended financial year ending 31st March 2024 [covering a period of 15 months (comprising five quarters) commencing from 1st January 2023 to 31st March 2024] shall be considered by the Board of Directors of the Company at their meeting scheduled on Thursday 25th April 2024 and the Trading Window in respect of the equity shares of the Company shall remain closed from 1st April 2024 to 27th April 2024 (both days inclusive) in view of the above event. NESTLE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2024 ,inter alia, to consider and approve Update on board meeting scheduled on 25th April 2024 - Board of Directors to also consider recommendation of final dividend for the financial year 2023-24, if any, for the approval of the members at the ensuing Annual General Meeting (As Per BSE Announcement Dated on 11/04/2024) Outcome of Board Meeting 1. Audited Financial Results for the fifteen months financial year ended 31st March 2024: 2. Recommended Final Dividend of Rs. 8.50/- (Eight Rupees and Fifty Paisa only) per equity shares of Re. 1/- each for the fifteen months financial year ended 31st March 2024 on the entire issued, subscribed and paid-up share capital of the Company of 964,157,160 equity shares of nominal value of Re. 1/- (Rupee one only) each. 3. Approved execution of a definitive agreement to form a joint venture between the Company and Dr. Reddy's Laboratories Limited ('Dr. Reddy's') to bring together the well-known global range of nutritional health solutions as well as vitamins, minerals and health supplements of Nestlé Health Science with the nutraceuticals portfolios, strong and established commercial strengths of Dr. Reddy's in India and other geographies as may be agreed by the Parties. The joint venture is expected to become operational in the second quarter of the financial year 2024-25, subject to customary closing conditions. 4. Approved launch of Nespresso in India wherein the Company will engage in the sale and distribution of Nespresso products (machines and capsules) through its distribution network, online channels, and boutiques under commercial arrangements with Nespresso and third parties. The Company expects to launch Nespresso in India by the end of 2024. Enclosed is the Press Release relating to the results and other business items as mentioned above. 5. Approved convening of the 65 th AGM of the Company on Friday, 5th July 2024 through Video Conferencing/ Other Audio-Visual Means (VC/ OAVM) and fixed Monday, 15 th July 2024 as Record Date for the purpose of determining entitlement of the Members to the Final Dividend for the fifteen months financial year ended 31st March 2024. The Final Dividend for the fifteen months financial year ended 31st March 2024, if approved by the Members at 65 th AGM, shall be paid on and from 2nd August 2024. Enclosed is the intimation of the Record Date. Soft copy of the Annual Report and Notice of the 65 th AGM shall be sent in due course. The same shall also be uploaded on the Company's website at www.nestle.in. (As Per BSE Announcement Dated on 25.04.2024)
05-Apr-2024 05-Apr-2024 a. Approved appointment of Ms Suneeta Reddy (DIN: 00001873) as an Additional Director and Independent Non-Executive Director of the Company for a term of five consecutive years with effect from 5th April 2024, and recommended to the Members of the Company for their approval; b. Approved payment of general licence fees (royalty) by the Company to Société des Produits Nestlé S.A. (Licensor), and recommended to the Members of the Company for their approval
19-Dec-2023 07-Feb-2024 NESTLE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve Schedule for consideration of the Financial Results of the Company by the Board of Directors during 2024 and corresponding Trading Window Closure Period. Please refer our communication no. PKR:SG: 49:23 dated 27th July 2023 intimating that the Board of Directors at its meeting held on 27th July 2023 approved change in the Financial Year of the Company from 1st January - 31st December to 1st April - 31st March and accordingly extended the current Financial Year of the Company upto 31st March 2024 covering a period of 15 months (comprising five quarters) commencing from 1st January 2023 to 31st March 2024. All subsequent Financial Years of the Company would begin from 1st April every year and end with 31st March of the following year. Declaration of Third Interim Dividend of Rs. 7/- per Equity Share of the face value of Re. 1/- each for the Financial Year 2023-24 1. Unaudited Financial Results for the fourth quarter and tweleve months ended 31st December 2023; 2. declaration of third interim dividend for the Financial Year 2023-24; and 3. sale of Nestle Business Services Division of the Company to a related party. I. Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'): Unaudited Financial Results for the fourth quarter and twelve months ended 31st December 2023; II. Regulation 30 read with Schedule-III to the Listing Regulations: a. declaration of Third Interim Dividend for the Financial Year 2023-24; and b. sale of Nestlé Business Services ('NBS') Division of the Company to a related party. (As Per BSE Announcement Dated on 07.02.2024)
26-Sep-2023 19-Oct-2023 NESTLE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2023 inter alia to consider and approve Further to our letter dated PKR:GA:54:22 dated 22nd December 2022 the un-audited financial results of the Company for the third quarter and nine months ending 30th September 2023 shall be considered by the Board of Directors of the Company at their meeting scheduled on Thursday 19th October 2023 and the Trading Window in respect of the equity shares of the Company shall remain closed from 1st October 2023 to 21st October 2023 (both days inclusive) in view of the above event. Declaration of Second Interim Dividend of 2023 Sub-division/split of existing equity shares of face value 10/- each (Rs. Ten only) fully paid up, by alteration of capital clause of the MOA of the Company Unaudited Financial Results for the quarter ended 30th September 2023 Sub-division/split of existing equity shares of face value 10/- each, fully paid up by alteration of the Capital Clause of MOA of the Compnay Record Date for Second Interim Dividend is 1st November 2023 Outcome of the Board Meeting of Q3 results, dividend and split of shares (As Per BSE Announcement Dated on 19/10/2023)
26-Jun-2023 27-Jul-2023 NESTLE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve Further to our letter PKR:GA:54:22 dated 22nd December 2022 the un-audited financial results of the Company for the second quarter and half year ending 30th June 2023 shall be considered by the Board of Directors of the Company at their meeting proposed to be held on Thursday 27th July 2023 and the Trading Window in respect of the equity shares of the Company shall remain closed from 1st July 2023 to 29th July 2023 (both days inclusive) in view of the above event. 1. Unaudited Financial Results for the second quarter and half year ended 30th June 2023; 2. Intimation to change the Financial Year of the Company to the Fiscal Year i.e., April to March cycle. The meeting of the Board of Directors commenced at 09:00 hours and the above agenda items concluded at 10:20 hours. Unaudited Financial Results for the second quarter and half year ended 30.06.2023 Regulation 30: Intimation to change the Financial Year of the Company to the Fiscal Year i.e. April to March cycle, subject to approvals (As Per BSE Announcement Dated on 27.07.2023)

NIFTY:22,502.00  Up arrow
35.90(0.16%)
SENSEX:73,917.03  Up arrow
88.91(0.12%)

Product

Trading


Useful links

Who we are

Connect with us

Stay on top of the markets with our bite-sized newsletter delivered right to your Inbox!

footer-arrow-icon
appstore appstore

#1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Arihant Capital Markets Limited is a SEBI registered stock broker and depository participant. SEBI Registration number for NSE & BSE :- INZ000180939; NSDL - IN-DP-127-2015 DP ID-IN301983; CDSL DP ID-43000;NCDEX - 01274; MCX - 56565; AMFI - ARN 15114; SEBI Merchant Banking Reg. No. - MB INM000011070; SEBI Research Analyst Reg. No. - INH000002764. Registered Address: 6, Lad colony, Y.N. Road, Indore – 452001.Corporate office address: #1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Please carefully read the risk disclosure document as prescribed by SEBI, as well as the 'Do’s and Don’ts' provided by NSE, BSE, NCDEX, and MCX. If you have any complaints related to securities broking, kindly contact us at complaint@arihantcapital.com. For DP-related matters, please reach out to us at depository@arihantcapital.com.

If you want to register your complaints through SEBI Score Portal please click here. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

Investments in securities market are subject to market risks; read all the related documents carefully before investing.

Disclaimer: Arihant Capital Markets Limited is engaged in client based and proprietary trading on various exchanges.

  • ATTENTION INVESTORS :
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • For Stock Broking Transaction 'Prevent unauthorised transactions in your account - update your mobile numbers/email IDs with your stockbrokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.
  • For Depository Transaction 'Prevent Unauthorized Transactions in your demat account - Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day.
  • If you are subscribing to an IPO, there is no need to issue cheques. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.
  • Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Awareness regarding guidelines of margin collection:
1)Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
2)Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
3)Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.
Issued in the interest of investors

Dear Investor - As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor. https://www.bseipf.com/investors_education.html

Copyright © 2019 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)